CLINICAL_TRIALS
trial_result
· 2018-12-14
Clinical Trial Update: Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in Schizophrenia [Phase 4]
Summary
A Phase 4 randomized double-blind trial comparing aripiprazole and risperidone in schizophrenia was terminated with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kettering Health Network | Conditions: Schizophrenia | Phase 4 | Status: TERMINATED | Results posted: 2018-12-14